The Home Care Testing Market size was estimated at US$ 9.08 Billion in 2022 it is predicted to grow at a CAGR of 9.34% from 2023 to 2032 to reach around US$ 22.18 Billion by the end of 2032.
The Home Care Testing Market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market
The study offers intricate dynamics about different aspects of the global Home Care Testing Market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global Home Care Testing Market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Bn) and volume (tons).
Sample Link @ https://www.visionresearchreports.com/report/sample/40522
Report Scope of the Home Care Testing Market
| Report Coverage | Details |
| Revenue Share of North America in 2022 | 33% |
| Revenue Forecast by 2032 | USD 22.18 billion |
| Growth Rate from 2023 to 2032 | CAGR of 9.34% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | Abbott; BD; Quidel Corp.; BioSure; F. Hoffmann-La Roche Ltd.; Nova Biomedical; Siemens Healthcare GmbH; ACON Laboratories, Inc.; OraSure Technologies, Inc.; Chembio Diagnostics, Inc |
This study covers an elaborate segmentation of the global Home Care Testing Market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global Home Care Testing Market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.
Key Players
Abbott; BD; Quidel Corp.; BioSure; F. Hoffmann-La Roche Ltd.; Nova Biomedical; Siemens Healthcare GmbH; ACON Laboratories, Inc.; OraSure Technologies, Inc.; Chembio Diagnostics, Inc
Market Segmentation
By Age
- Pediatric
- Adult
- Geriatric
By Sample
- Urine
- Saliva
- Blood
- Others
By Test Type
- HIV Test Kit
- Diabetes and Glucose Tests
- Cholesterol and Triglycerides Tests
- Pregnancy Tests
- Infectious Diseases Tests
- Urinary Tract Infection Tests
- Others
By Distribution channel
- Retail Pharmacies
- Supermarket/Hypermarket
- Online Pharmacies
By Product
- Strip
- Cassette
- Test Panel
- Midstream
- Dip Card
- Others
By Regional
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Research Methodology
The research methodology acquire by analysts for assemble the global Home Care Testing Market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global Home Care Testing Market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Home Care Testing Market
5.1. COVID-19 Landscape: Home Care Testing Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Home Care Testing Market, By Age
8.1. Home Care Testing Market, by Age, 2023-2032
8.1.1. Pediatric
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Adult
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Geriatric
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Home Care Testing Market, By Sample
9.1. Home Care Testing Market, by Sample, 2023-2032
9.1.1. Urine
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Saliva
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Blood
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Home Care Testing Market, By Test Type
10.1. Home Care Testing Market, by Test Type, 2023-2032
10.1.1. HIV Test Kit
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Diabetes and Glucose Tests
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Cholesterol and Triglycerides Tests
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Pregnancy Tests
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Infectious Diseases Tests
10.1.5.1. Market Revenue and Forecast (2020-2032)
10.1.6. Urinary Tract Infection Tests
10.1.6.1. Market Revenue and Forecast (2020-2032)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Home Care Testing Market, By Distribution
11.1. Home Care Testing Market, by Distribution, 2023-2032
11.1.1. Retail Pharmacies
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Supermarket/Hypermarket
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Online Pharmacies
11.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Home Care Testing Market, By Product
12.1. Home Care Testing Market, by Product, 2023-2032
12.1.1. Strip
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Cassette
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Test Panel
12.1.3.1. Market Revenue and Forecast (2020-2032)
12.1.4. Midstream
12.1.4.1. Market Revenue and Forecast (2020-2032)
12.1.5. Dip Card
12.1.5.1. Market Revenue and Forecast (2020-2032)
12.1.6. Others
12.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Home Care Testing Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Age (2020-2032)
13.1.2. Market Revenue and Forecast, by Sample (2020-2032)
13.1.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.1.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.1.5. Market Revenue and Forecast, by Product (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Age (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Sample (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.1.6.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.1.7. Market Revenue and Forecast, by Product (2020-2032)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Age (2020-2032)
13.1.8.2. Market Revenue and Forecast, by Sample (2020-2032)
13.1.8.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.1.8.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.1.8.5. Market Revenue and Forecast, by Product (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Age (2020-2032)
13.2.2. Market Revenue and Forecast, by Sample (2020-2032)
13.2.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.2.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.2.5. Market Revenue and Forecast, by Product (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Age (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Sample (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.2.7. Market Revenue and Forecast, by Distribution (2020-2032)
13.2.8. Market Revenue and Forecast, by Product (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Age (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Sample (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.2.10. Market Revenue and Forecast, by Distribution (2020-2032)
13.2.11. Market Revenue and Forecast, by Product (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Age (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Sample (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.2.12.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.2.13. Market Revenue and Forecast, by Product (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Age (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Sample (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.2.14.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.2.15. Market Revenue and Forecast, by Product (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Age (2020-2032)
13.3.2. Market Revenue and Forecast, by Sample (2020-2032)
13.3.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.3.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.3.5. Market Revenue and Forecast, by Product (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Age (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Sample (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.3.6.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.3.7. Market Revenue and Forecast, by Product (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Age (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Sample (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.3.8.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.3.9. Market Revenue and Forecast, by Product (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Age (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Sample (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.3.10.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.3.10.5. Market Revenue and Forecast, by Product (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Age (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Sample (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.3.11.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.3.11.5. Market Revenue and Forecast, by Product (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Age (2020-2032)
13.4.2. Market Revenue and Forecast, by Sample (2020-2032)
13.4.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.4.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.4.5. Market Revenue and Forecast, by Product (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Age (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Sample (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.4.6.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.4.7. Market Revenue and Forecast, by Product (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Age (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Sample (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.4.8.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.4.9. Market Revenue and Forecast, by Product (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Age (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Sample (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.4.10.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.4.10.5. Market Revenue and Forecast, by Product (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Age (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Sample (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.4.11.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.4.11.5. Market Revenue and Forecast, by Product (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Age (2020-2032)
13.5.2. Market Revenue and Forecast, by Sample (2020-2032)
13.5.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.5.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.5.5. Market Revenue and Forecast, by Product (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Age (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Sample (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.5.6.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.5.7. Market Revenue and Forecast, by Product (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Age (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Sample (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Test Type (2020-2032)
13.5.8.4. Market Revenue and Forecast, by Distribution (2020-2032)
13.5.8.5. Market Revenue and Forecast, by Product (2020-2032)
Chapter 14. Company Profiles
14.1. Abbott
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. BD
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Quidel Corp.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. BioSure
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. F. Hoffmann-La Roche Ltd.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Nova Biomedical
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Siemens Healthcare GmbH
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. ACON Laboratories, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. OraSure Technologies, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Chembio Diagnostics, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Vision Research Reports
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168